(Q34559865)
Statements
No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials (English)
David C Linch
Panagiotis D Kottaridis
Sivatharsini Srirangan
Keith Wheatley